Cargando…
The Role of GSK3β in T Lymphocytes in the Tumor Microenvironment
Immunotherapy options for patients with cancer have emerged following decades of research on immune responses against tumors. Most treatments in this category harness T cells with specificity for tumor associated antigens, neoantigens, and cancer-testis antigens. GSK3β is a serine-threonine kinase w...
Autores principales: | Dimou, Anastasios, Syrigos, Konstantinos N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396595/ https://www.ncbi.nlm.nih.gov/pubmed/32850361 http://dx.doi.org/10.3389/fonc.2020.01221 |
Ejemplares similares
-
GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation
por: Hassan, Ghmkin, et al.
Publicado: (2023) -
Immune microenvironment dynamics in breast cancer during pregnancy: impact of gestational age on tumor-infiltrating lymphocytes and prognosis
por: Sajjadi, Elham, et al.
Publicado: (2023) -
GSK-3 and mitochondria in cancer cells
por: Chiara, Federica, et al.
Publicado: (2013) -
From the Bench to Bedside: Biological and Methodology Considerations for the Future of Companion Diagnostics in Nonsmall Cell Lung Cancer
por: Dimou, Anastasios, et al.
Publicado: (2011) -
Perplexing Role of P-Glycoprotein in Tumor Microenvironment
por: Robinson, Kianna, et al.
Publicado: (2020)